Genome Canada is delighted to highlight the recent appointment of five new members to its Board of Directors. They include:
Fiona Brinkman, Professor, Molecular Biology and Biochemistry at Simon Fraser University
Jay Ingram, Broadcaster and Science Writer
Kim McConnell, Founder and former CEO, AdFarm
Moura Quayle, Professor, Strategic Design, Sauder School of Business, University of British Columbia
Donald Ziraldo, Co-founder, Inniskillin Wines
The Structural Genomics Consortium (SGC) announced today that Janssen Pharmaceuticals NV has joined its group to partner in the investigation of epigenetics-based drug research, a new and burgeoning field in the development of future medicines.
Dr. Abdallah Daar, Professor of Public Health at the University of Toronto and a Genome Canada Board member since 2012, has been appointed to a new Scientific Advisory Board of the United Nations. Dr. Daar is one of twenty-six eminent scientists appointed to the Board, representing natural, social and human sciences and engineering.
Dr. Fabrice Brunet, Chief Executive Officer at Sainte-Justine UHC, and Marc LePage, President and CEO of Génome Québec, are extremely proud to announce the launch of Canada’s first integrated clinical genomic centre in pediatrics, an initiative currently at the forefront of global efforts in this area. "We are honoured to have the opportunity to make this partnership a reality in the presence of the Québec Premier, Pauline Marois, and Dr.
Genome Canada applauds the federal government’s Speech from the Throne, commending the government’s pledge to protect and promote traditional resource sectors.
The goal of the “Research Catalyst Network: Expediting collaboration between basic and clinician scientists in functional studies of novel rare disease genes” is to establish a national consortium that will enable clinical geneticists who are identifying rare disease gene mutations to collaborate with model organism researchers with expertise in the cognate gene’s function.